Cber PowerPoint PPT Presentations

All Time
Show:
Recommended
Sort by:
CBERS Program: An Overview PowerPoint PPT Presentation
CBERS Program: An Overview - Prepared by Jos Carlos Epiphanio (CBERS Application Program Manager) and ... Payload bit rate: 53 Mb/sec x 2 (CBERS-1,2) 150 Mb/sec x 2 (CBERS-3,4) ...
Prepared by Jos Carlos Epiphanio (CBERS Application Program Manager) and ... Payload bit rate: 53 Mb/sec x 2 (CBERS-1,2) 150 Mb/sec x 2 (CBERS-3,4) ...
| PowerPoint PPT presentation | free to download
CBERS: the Brazilian Experience PowerPoint PPT Presentation
CBERS: the Brazilian Experience - CBERS: the Brazilian Experience. Gilberto Camara. Director for Earth Observation. INPE ... Landsat TM images to evaluate deforestation in the Brazilian Amazon ...
CBERS: the Brazilian Experience. Gilberto Camara. Director for Earth Observation. INPE ... Landsat TM images to evaluate deforestation in the Brazilian Amazon ...
| PowerPoint PPT presentation | free to download
CBER%20510(k)%20Issues PowerPoint PPT Presentation
CBER%20510(k)%20Issues - Title: FDA Perspective on the Implementation of Electronic Systems in the Blood Establishment Subject: Electronic Systems in the Blood Establishment
Title: FDA Perspective on the Implementation of Electronic Systems in the Blood Establishment Subject: Electronic Systems in the Blood Establishment
| PowerPoint PPT presentation | free to download
FDA/CBER VRBPAC Meeting PowerPoint PPT Presentation
FDA/CBER VRBPAC Meeting - Demonstrate use of reverse genetics to generate H5 vaccine reference viruses and ... Reverse cumulative distribution of MN antibody at day 56 (28 days after dose 2) ...
Demonstrate use of reverse genetics to generate H5 vaccine reference viruses and ... Reverse cumulative distribution of MN antibody at day 56 (28 days after dose 2) ...
| PowerPoint PPT presentation | free to view
Implementation of the CTD: CBER PowerPoint PPT Presentation
Implementation of the CTD: CBER - The question is NOT 'Will CBER be accepting the CTD instead of the BLA? ... BLA/Form 356h Issuance of Guidances ... CTD to BLA 'Specified Products' currently ...
The question is NOT 'Will CBER be accepting the CTD instead of the BLA? ... BLA/Form 356h Issuance of Guidances ... CTD to BLA 'Specified Products' currently ...
| PowerPoint PPT presentation | free to view
CBER Manufacturing Changes PowerPoint PPT Presentation
CBER Manufacturing Changes - Proposed Rule, Federal Register, Vol. 61, No. 19, 2739, Monday ... Virus/adventitious agent removal/inactivation. Source material or cell line. C. B. E. R ...
Proposed Rule, Federal Register, Vol. 61, No. 19, 2739, Monday ... Virus/adventitious agent removal/inactivation. Source material or cell line. C. B. E. R ...
| PowerPoint PPT presentation | free to view
CBER Research Collaborative PowerPoint PPT Presentation
CBER Research Collaborative - Support schools, districts, and states in adopting, implementing, ... Alphabetics Woodcock Language Proficiency Battery- R. Decoding WLPB-Revised: Word Attack ...
Support schools, districts, and states in adopting, implementing, ... Alphabetics Woodcock Language Proficiency Battery- R. Decoding WLPB-Revised: Word Attack ...
| PowerPoint PPT presentation | free to view
Update on CBER HIV-1 Subtype panel PowerPoint PPT Presentation
Update on CBER HIV-1 Subtype panel - Update on CBER HIV-1 Subtype panel Indira Hewlett, Ph.D CBER/FDA CBER HIV-1 subtype panel 20 specimens representing subtypes A-G of group M, N and O 2 isolates of ...
Update on CBER HIV-1 Subtype panel Indira Hewlett, Ph.D CBER/FDA CBER HIV-1 subtype panel 20 specimens representing subtypes A-G of group M, N and O 2 isolates of ...
| PowerPoint PPT presentation | free to view
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA PowerPoint PPT Presentation
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA - Division of Bacterial, Parasitic and Allergenic Products. OVRR/CBER/FDA ... Label/promotional activity review. Consultations with outside organizations ...
Division of Bacterial, Parasitic and Allergenic Products. OVRR/CBER/FDA ... Label/promotional activity review. Consultations with outside organizations ...
| PowerPoint PPT presentation | free to download
CDRH CBER TSE INSTRUMENT DECONTAMINATION PROJECT PowerPoint PPT Presentation
CDRH CBER TSE INSTRUMENT DECONTAMINATION PROJECT - soak in NaOH or Bleach, rinse. then steam autoclave, 1 hr ... autoclaving and bleach killed them all. tried 'modified' WHO protocols: ...
soak in NaOH or Bleach, rinse. then steam autoclave, 1 hr ... autoclaving and bleach killed them all. tried 'modified' WHO protocols: ...
| PowerPoint PPT presentation | free to download
CBER Research: Overview Management PowerPoint PPT Presentation
CBER Research: Overview Management - ... 2 Improve clinical trial design and evaluation, including adaptive design approaches Develop formal risk management and risk assessment approaches Enhance ...
... 2 Improve clinical trial design and evaluation, including adaptive design approaches Develop formal risk management and risk assessment approaches Enhance ...
| PowerPoint PPT presentation | free to view
Combination Products CBER Report PowerPoint PPT Presentation
Combination Products CBER Report - The Office will handle disputes involving timeliness, unless 'clearly premarket' 7 ... What is the true extent of this authority? 10. Office's Report to ...
The Office will handle disputes involving timeliness, unless 'clearly premarket' 7 ... What is the true extent of this authority? 10. Office's Report to ...
| PowerPoint PPT presentation | free to view
A Ground Control System for CBERS 3 and 4 Satellites PowerPoint PPT Presentation
A Ground Control System for CBERS 3 and 4 Satellites - SCD 1, 2. CBERS 2B, 3, 4. EQUARS. MIRAX. Application Layer. TMTC Processing Kernel ... SIMS. Automation Layer. Semi-Automated. Automate routine operations: ...
SCD 1, 2. CBERS 2B, 3, 4. EQUARS. MIRAX. Application Layer. TMTC Processing Kernel ... SIMS. Automation Layer. Semi-Automated. Automate routine operations: ...
| PowerPoint PPT presentation | free to view
Update on CBER HIV-1 Subtype panel PowerPoint PPT Presentation
Update on CBER HIV-1 Subtype panel - 21 confirmed from 14 blood donations. 19 are not transfusion related, ... NAT may be the most appropriate strategy to interdict infectious donations ...
21 confirmed from 14 blood donations. 19 are not transfusion related, ... NAT may be the most appropriate strategy to interdict infectious donations ...
| PowerPoint PPT presentation | free to view
Earth observation data for everyone: the CBERS experience PowerPoint PPT Presentation
Earth observation data for everyone: the CBERS experience - Uncle Scrooge and the Internet. Uncle Scrooge: 'A penny saved is a penny earned' The anti-Uncle Scrooge principle: 'A pixel saved is a penny wasted' Why is that so? ...
Uncle Scrooge and the Internet. Uncle Scrooge: 'A penny saved is a penny earned' The anti-Uncle Scrooge principle: 'A pixel saved is a penny wasted' Why is that so? ...
| PowerPoint PPT presentation | free to view
CBERs Blood Safety Team Blood Products Advisory Committee PowerPoint PPT Presentation
CBERs Blood Safety Team Blood Products Advisory Committee - Military (2% of collections) Hospital Transfusion Services - ~5,000 ... Test Kits, Blood Grouping Reagents. Apheresis machines, blood warmers, etc. ...
Military (2% of collections) Hospital Transfusion Services - ~5,000 ... Test Kits, Blood Grouping Reagents. Apheresis machines, blood warmers, etc. ...
| PowerPoint PPT presentation | free to view
CBER's policies on assay regulation: Definitions of assay performance characteristics PowerPoint PPT Presentation
CBER's policies on assay regulation: Definitions of assay performance characteristics - Interfering substances/conditions. Specificity (general) False positives ... Interfering substances/conditions. Reproducibility. Run-run. Site-site. Operator-operator ...
Interfering substances/conditions. Specificity (general) False positives ... Interfering substances/conditions. Reproducibility. Run-run. Site-site. Operator-operator ...
| PowerPoint PPT presentation | free to download
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA PowerPoint PPT Presentation
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA - Bordetella pertussis, Bacillus anthracis, and Yersinia spp. ... Identification of iron utilization systems in Bacillus anthracis. Glycobiology ...
Bordetella pertussis, Bacillus anthracis, and Yersinia spp. ... Identification of iron utilization systems in Bacillus anthracis. Glycobiology ...
| PowerPoint PPT presentation | free to download
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA PowerPoint PPT Presentation
Division of Bacterial, Parasitic and Allergenic Products OVRR/CBER/FDA - Characterization of immune responses to polysaccharide and conjugate vaccines ... Characterization of innovative approaches to vaccine development, and evaluation ...
Characterization of immune responses to polysaccharide and conjugate vaccines ... Characterization of innovative approaches to vaccine development, and evaluation ...
| PowerPoint PPT presentation | free to download
The CBERS satellite, data policy and social benefits PowerPoint PPT Presentation
The CBERS satellite, data policy and social benefits - Our answer: Make all sectors of society use publically funded EO data... Small size of commercial earth observation markert. Not enough income for R&D investment ...
Our answer: Make all sectors of society use publically funded EO data... Small size of commercial earth observation markert. Not enough income for R&D investment ...
| PowerPoint PPT presentation | free to download
Type V Drug Master Files: Comments from CBERs Viewpoint PowerPoint PPT Presentation
Type V Drug Master Files: Comments from CBERs Viewpoint - ... to manufacture clinical products, especially gene therapy products, or where ... for production of gene or cellular based therapies under clinical trials ...
... to manufacture clinical products, especially gene therapy products, or where ... for production of gene or cellular based therapies under clinical trials ...
| PowerPoint PPT presentation | free to view
Review of Site Visit Report Laboratory of Molecular Virology DETTD/OBRR/CBER March 18, 2005 Hira L. Nakhasi, Ph.D. Director, DETTD PowerPoint PPT Presentation
Review of Site Visit Report Laboratory of Molecular Virology DETTD/OBRR/CBER March 18, 2005 Hira L. Nakhasi, Ph.D. Director, DETTD - Title: Division of Emerging and Transfusion Transmitted Diseases Hira L. Nakhasi, Ph.D. Director, DETTD Author: CBER Last modified by: CBER Created Date
Title: Division of Emerging and Transfusion Transmitted Diseases Hira L. Nakhasi, Ph.D. Director, DETTD Author: CBER Last modified by: CBER Created Date
| PowerPoint PPT presentation | free to view
Site Visit Report Review of Intramural Research Office of Blood Research and Review CBER, FDA PowerPoint PPT Presentation
Site Visit Report Review of Intramural Research Office of Blood Research and Review CBER, FDA - Clinical research. Blood collection. Industry. OBRR Intramural Research Review ... Review intent: Overarching summary of research program's goals and support ...
Clinical research. Blood collection. Industry. OBRR Intramural Research Review ... Review intent: Overarching summary of research program's goals and support ...
| PowerPoint PPT presentation | free to view
Alianzas Cber Ciudadanas PowerPoint PPT Presentation
Alianzas Cber Ciudadanas - Miedo a la publicidad negativa. Dar ventajas a la competencia. ... Cada regi n o localidad deber a contar con unidad policial, y una judicial, de c ber crimen. ...
Miedo a la publicidad negativa. Dar ventajas a la competencia. ... Cada regi n o localidad deber a contar con unidad policial, y una judicial, de c ber crimen. ...
| PowerPoint PPT presentation | free to view
Parvovirus B19 NAT Screening and Infectivity Mei-ying W Yu CBER/FDA SoGAT XVI Paul Ehrlich Institut July 03, 2003 PowerPoint PPT Presentation
Parvovirus B19 NAT Screening and Infectivity Mei-ying W Yu CBER/FDA SoGAT XVI Paul Ehrlich Institut July 03, 2003 - Pending a policy on screening Whole Blood donations, FDA need not require ... process' test (i.e., not performed pre-release as part of a determination of ...
Pending a policy on screening Whole Blood donations, FDA need not require ... process' test (i.e., not performed pre-release as part of a determination of ...
| PowerPoint PPT presentation | free to view
B19 Testing of Plasma for Fractionation: Current Thinking Mei-ying W Yu, PhD Division of Hematology CBER/FDA SoGAT XVII May 26-27, 2004 PowerPoint PPT Presentation
B19 Testing of Plasma for Fractionation: Current Thinking Mei-ying W Yu, PhD Division of Hematology CBER/FDA SoGAT XVII May 26-27, 2004 - ... NAT screening is an in-process test ... Testing for B19 has not been ... titer donors, but only if donor notification can be completed within several ...
... NAT screening is an in-process test ... Testing for B19 has not been ... titer donors, but only if donor notification can be completed within several ...
| PowerPoint PPT presentation | free to download
September 18, 2003 PowerPoint PPT Presentation
September 18, 2003 - Title: CBER initiated the Blood Action Plan in July 1997. The objectives of the plan were twofold: to increase the effectiveness of CBER's scientific and regulatory ...
Title: CBER initiated the Blood Action Plan in July 1997. The objectives of the plan were twofold: to increase the effectiveness of CBER's scientific and regulatory ...
| PowerPoint PPT presentation | free to download
Process%20of%20FDA%20New%20Drug%20Approval: PowerPoint PPT Presentation
Process%20of%20FDA%20New%20Drug%20Approval: - Process of FDA New Drug Approval: 1- New Compound with promising ... SCIENCE: Trials will allow to asses safety. And effectiveness. FDA. CBER/ CDER. Sponsor ...
Process of FDA New Drug Approval: 1- New Compound with promising ... SCIENCE: Trials will allow to asses safety. And effectiveness. FDA. CBER/ CDER. Sponsor ...
| PowerPoint PPT presentation | free to download
Validation of Virus Removal PowerPoint PPT Presentation
Validation of Virus Removal - Title: Validation of Virus Removal Author: FDA / CBER Last modified by: CBER Created Date: 6/24/1999 12:50:08 AM Document presentation format: On-screen Show
Title: Validation of Virus Removal Author: FDA / CBER Last modified by: CBER Created Date: 6/24/1999 12:50:08 AM Document presentation format: On-screen Show
| PowerPoint PPT presentation | free to view
RISK MANAGEMENT PUBLIC WORKSHOP PowerPoint PPT Presentation
RISK MANAGEMENT PUBLIC WORKSHOP - RISK MANAGEMENT CDER/CBER EXECUTIVE OVERSIGHT COMMITTEE. Steven Galson, Chair Paul Seligman, Vice-Chair. Miles Braun, CBER Lead Helen Winkle ...
RISK MANAGEMENT CDER/CBER EXECUTIVE OVERSIGHT COMMITTEE. Steven Galson, Chair Paul Seligman, Vice-Chair. Miles Braun, CBER Lead Helen Winkle ...
| PowerPoint PPT presentation | free to view
Wei Liang, Ph.D. PowerPoint PPT Presentation
Wei Liang, Ph.D. - Mitochondrial Manipulation Technologies: Preclinical Considerations Wei Liang, Ph.D. FDA / CBER / OCTGT Wei.liang@fda.hhs.gov Ethical and Social Policy Considerations ...
Mitochondrial Manipulation Technologies: Preclinical Considerations Wei Liang, Ph.D. FDA / CBER / OCTGT Wei.liang@fda.hhs.gov Ethical and Social Policy Considerations ...
| PowerPoint PPT presentation | free to view
Writing and Collaboration: A First Year Reflection in Questions PowerPoint PPT Presentation
Writing and Collaboration: A First Year Reflection in Questions - Research Scientist, Center for Behavioral Education & Research (CBER) ... Questions, Comments, Witty Observations? mike.fl@uconn.edu. www.cber.uconn.edu. Thank you! ...
Research Scientist, Center for Behavioral Education & Research (CBER) ... Questions, Comments, Witty Observations? mike.fl@uconn.edu. www.cber.uconn.edu. Thank you! ...
| PowerPoint PPT presentation | free to view
A%20vision%20for%20the%20future%20of%20INPE%20in%20the%2021st%20century PowerPoint PPT Presentation
A%20vision%20for%20the%20future%20of%20INPE%20in%20the%2021st%20century - To us, there is no ambiguity of purpose. We do not have the fantasy of ... Payload Bit Rate. 166 Mbps. 303 Mbps. Lifetime. 2 years. 3 years. CBERS platform ...
To us, there is no ambiguity of purpose. We do not have the fantasy of ... Payload Bit Rate. 166 Mbps. 303 Mbps. Lifetime. 2 years. 3 years. CBERS platform ...
| PowerPoint PPT presentation | free to download
Good Clinical Practices and FDA Inspections PowerPoint PPT Presentation
Good Clinical Practices and FDA Inspections - Good Clinical Practices and. FDA Inspections. Patricia Holobaugh. Chief, Bioresearch Monitoring ... Expanded to cell therapies, and then to all CBER IND/IDEs ...
Good Clinical Practices and. FDA Inspections. Patricia Holobaugh. Chief, Bioresearch Monitoring ... Expanded to cell therapies, and then to all CBER IND/IDEs ...
| PowerPoint PPT presentation | free to download
Facility Design and CGMP Considerations for Cell Therapy Products PowerPoint PPT Presentation
Facility Design and CGMP Considerations for Cell Therapy Products - Facility Design and CGMP Considerations for Cell Therapy Products James Crim HHS/FDA/CBER/OCBQ/DMPQ ISCT- 6th Annual Symposium September 25-27, 2006
Facility Design and CGMP Considerations for Cell Therapy Products James Crim HHS/FDA/CBER/OCBQ/DMPQ ISCT- 6th Annual Symposium September 25-27, 2006
| PowerPoint PPT presentation | free to download
Comparability Protocols, Manufacturing Changes, and CMC Issues PowerPoint PPT Presentation
Comparability Protocols, Manufacturing Changes, and CMC Issues - Renews the Prescription Drug User Fee Program with amendments (PDUFA 2) ... http://www.fda.gov/cber/cberftp.html. CHARACTER@a1.cber.fda.gov. C. B. E. R ...
Renews the Prescription Drug User Fee Program with amendments (PDUFA 2) ... http://www.fda.gov/cber/cberftp.html. CHARACTER@a1.cber.fda.gov. C. B. E. R ...
| PowerPoint PPT presentation | free to view
Surveillance of HIV variants in Cameroon and evaluation of their impact on HIV diagnostics PowerPoint PPT Presentation
Surveillance of HIV variants in Cameroon and evaluation of their impact on HIV diagnostics - Surveillance of HIV variants in Cameroon and evaluation of their impact on HIV diagnostics Indira K. Hewlett, Ph.D Chief, Laboratory of Molecular Virology, CBER, FDA
Surveillance of HIV variants in Cameroon and evaluation of their impact on HIV diagnostics Indira K. Hewlett, Ph.D Chief, Laboratory of Molecular Virology, CBER, FDA
| PowerPoint PPT presentation | free to download
Issues of Simultaneous Tests for Non-Inferiority and Superiority PowerPoint PPT Presentation
Issues of Simultaneous Tests for Non-Inferiority and Superiority - Title: Choice of Delta in Equivalence Testing Author: CBER Last modified by: FDA Created Date: 1/26/2001 7:10:25 PM Document presentation format
Title: Choice of Delta in Equivalence Testing Author: CBER Last modified by: FDA Created Date: 1/26/2001 7:10:25 PM Document presentation format
| PowerPoint PPT presentation | free to download
Laboratory of Immunobiochemistry site visit PowerPoint PPT Presentation
Laboratory of Immunobiochemistry site visit - LIB supports the regulatory mission of CBER and FDA in assuring the safety and ... expert advice. lot release data. BLA and IND review. 3 /19 ...
LIB supports the regulatory mission of CBER and FDA in assuring the safety and ... expert advice. lot release data. BLA and IND review. 3 /19 ...
| PowerPoint PPT presentation | free to view
Allergenic Extracts PowerPoint PPT Presentation
Allergenic Extracts - Allergenic Extracts Precipitates. Jennifer Bridgewater, M.P.H.. CBER, DBPAP ... Exceptions = some cat pelt extracts, intradermal tests with 50% glycerin ...
Allergenic Extracts Precipitates. Jennifer Bridgewater, M.P.H.. CBER, DBPAP ... Exceptions = some cat pelt extracts, intradermal tests with 50% glycerin ...
| PowerPoint PPT presentation | free to view
Facility Design and CGMP Considerations for Cell Therapy Products PowerPoint PPT Presentation
Facility Design and CGMP Considerations for Cell Therapy Products - Facility Design and CGMP Considerations for Cell Therapy Products James Crim HHS/FDA/CBER/OCBQ/DMPQ ISCT- 6th Annual Symposium September 25-27, 2006
Facility Design and CGMP Considerations for Cell Therapy Products James Crim HHS/FDA/CBER/OCBQ/DMPQ ISCT- 6th Annual Symposium September 25-27, 2006
| PowerPoint PPT presentation | free to download
Welcome to ULM PowerPoint PPT Presentation
Welcome to ULM - FYE: Summer Reading Program, Learning Communities, FRYS 101, Emerging Scholars. 129 new faculty in 3 years. Student Success Center, CBER. President's Lyceum Series ...
FYE: Summer Reading Program, Learning Communities, FRYS 101, Emerging Scholars. 129 new faculty in 3 years. Student Success Center, CBER. President's Lyceum Series ...
| PowerPoint PPT presentation | free to view
The Redesigned Donor History Questionnaire: The Abbreviated Donor Questionnaire Report of the Task Force to the FDA Blood Products Advisory Committee PowerPoint PPT Presentation
The Redesigned Donor History Questionnaire: The Abbreviated Donor Questionnaire Report of the Task Force to the FDA Blood Products Advisory Committee - Report of the Task Force to the FDA Blood Products Advisory Committee. December ... the Blood Donor History Questionnaire' sponsored by FDA, CBER, ABRA and AABB ...
Report of the Task Force to the FDA Blood Products Advisory Committee. December ... the Blood Donor History Questionnaire' sponsored by FDA, CBER, ABRA and AABB ...
| PowerPoint PPT presentation | free to download
Laboratory of Methods Development and Quality Control PowerPoint PPT Presentation
Laboratory of Methods Development and Quality Control - Credibility in the field. Problem solving approach ... CBER mouse immunogenicity test served as basis for ... Developing mouse immunogenicity test (potency) ...
Credibility in the field. Problem solving approach ... CBER mouse immunogenicity test served as basis for ... Developing mouse immunogenicity test (potency) ...
| PowerPoint PPT presentation | free to view
Non-NASA Missions For Terrestrial Science Applications PowerPoint PPT Presentation
Non-NASA Missions For Terrestrial Science Applications - No central overview on data use / access policies ... about available data records (e.g., 'Planet Action', ALOS K&C Mosaics, CBERS-2b, ...
No central overview on data use / access policies ... about available data records (e.g., 'Planet Action', ALOS K&C Mosaics, CBERS-2b, ...
| PowerPoint PPT presentation | free to download
Vascular Injury Expert Working Group 19 July NCSS Report PowerPoint PPT Presentation
Vascular Injury Expert Working Group 19 July NCSS Report - Expert Working Group. 19 July NCSS Report. Committee Members. David Essayan-CBER ... Expert Working Group. May 3-4 Minutes. Pathogenesis Model. decrease in ...
Expert Working Group. 19 July NCSS Report. Committee Members. David Essayan-CBER ... Expert Working Group. May 3-4 Minutes. Pathogenesis Model. decrease in ...
| PowerPoint PPT presentation | free to view
Center for Biologics Evaluation and Research, FDA PowerPoint PPT Presentation
Center for Biologics Evaluation and Research, FDA - 'The Researcher/Reviewer Model is essential to providing CBER with top-level ... Milan Blake, Ph.D.-Acting Director. Jay Slater, M.D.- Acting Deputy Director ...
'The Researcher/Reviewer Model is essential to providing CBER with top-level ... Milan Blake, Ph.D.-Acting Director. Jay Slater, M.D.- Acting Deputy Director ...
| PowerPoint PPT presentation | free to view
Beyond OGC Standards: The New Challenges for Open Source GIS PowerPoint PPT Presentation
Beyond OGC Standards: The New Challenges for Open Source GIS - CBERS ground stations will cover most of the Earth's land mass between 300N and 300S ... augmented reality. sensor networks. mobile devices. Open GIS-21 ...
CBERS ground stations will cover most of the Earth's land mass between 300N and 300S ... augmented reality. sensor networks. mobile devices. Open GIS-21 ...
| PowerPoint PPT presentation | free to download
TNF Blocker Safety: Lymphoma and Liver Failure PowerPoint PPT Presentation
TNF Blocker Safety: Lymphoma and Liver Failure - Tim Cot MD MPH, Chief, Therapeutics & Blood Safety Branch, DE/OBE/CBER/FDA. March 4, 2003 ... Clinicians and others can report adverse events associated with ...
Tim Cot MD MPH, Chief, Therapeutics & Blood Safety Branch, DE/OBE/CBER/FDA. March 4, 2003 ... Clinicians and others can report adverse events associated with ...
| PowerPoint PPT presentation | free to view
Center for Biologics Evaluation and Research PowerPoint PPT Presentation
Center for Biologics Evaluation and Research - Donor screening NAT assays licensed for HIV-1, HBV, HCV, WNV ... ISS 0498 (Italy) 1,700 1 Pos. CBER member #1 250 1b Neg (1000 copies/mL) ...
Donor screening NAT assays licensed for HIV-1, HBV, HCV, WNV ... ISS 0498 (Italy) 1,700 1 Pos. CBER member #1 250 1b Neg (1000 copies/mL) ...
| PowerPoint PPT presentation | free to view
Plans for International Standard for HIV-2 RNA and 2nd Second International Reference Panel for HIV-1 RNA Genotypes PowerPoint PPT Presentation
Plans for International Standard for HIV-2 RNA and 2nd Second International Reference Panel for HIV-1 RNA Genotypes - (In collaboration with Indira Hewlett, CBER/FDA) Current HIV Reference Reagents Available from NIBSC. 2nd International Standard for HIV-1 RNA. ...
(In collaboration with Indira Hewlett, CBER/FDA) Current HIV Reference Reagents Available from NIBSC. 2nd International Standard for HIV-1 RNA. ...
| PowerPoint PPT presentation | free to view
PHS Commissioned Corps Commissioned Corps Awards PowerPoint PPT Presentation
PHS Commissioned Corps Commissioned Corps Awards - Jesse L. Goodman Director, CBER. OPDIV Awards Coordinator ... CFSAN Ms. Dorothy Williams (301) 436-1744. CVM Ms. Linda Callahan (240) 276-9728 ...
Jesse L. Goodman Director, CBER. OPDIV Awards Coordinator ... CFSAN Ms. Dorothy Williams (301) 436-1744. CVM Ms. Linda Callahan (240) 276-9728 ...
| PowerPoint PPT presentation | free to view
DESIGNING A PROGRAM FOR REVIEW OF CDER LABORATORY RESEARCHERS PowerPoint PPT Presentation
DESIGNING A PROGRAM FOR REVIEW OF CDER LABORATORY RESEARCHERS - REP FROM HUMAN RESOURCES MANAGEMENT. EXEC SEC FROM OTR. OFFICE OF TESTING AND RESEARCH ... 1 HUMAN RESOURCE MANAGEMENT REP. 1 REP FROM CBER CENTER-DIRECTOR'S ...
REP FROM HUMAN RESOURCES MANAGEMENT. EXEC SEC FROM OTR. OFFICE OF TESTING AND RESEARCH ... 1 HUMAN RESOURCE MANAGEMENT REP. 1 REP FROM CBER CENTER-DIRECTOR'S ...
| PowerPoint PPT presentation | free to download
Development of Rapid HIV Tests for use in diagnostic settings PowerPoint PPT Presentation
Development of Rapid HIV Tests for use in diagnostic settings - Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD Supplemental Testing of ...
Supplemental Testing of Donors for HIV and HCV September 18, 2003 BPAC Meeting Robin Biswas, M.D. Indira Hewlett, Ph.D. FDA/CBER/OBRR/DETTD Supplemental Testing of ...
| PowerPoint PPT presentation | free to download
Classification of HLA Devices FDA Introduction PowerPoint PPT Presentation
Classification of HLA Devices FDA Introduction - Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA Objectives Provide an overview of the current regulatory status of HLA ...
Classification of HLA Devices FDA Introduction & Background Sheryl A. Kochman CBER/OBRR/DBA Objectives Provide an overview of the current regulatory status of HLA ...
| PowerPoint PPT presentation | free to view


Home About Us Terms and Conditions Privacy Policy Contact Us
Copyright 2024 CrystalGraphics, Inc. — All rights Reserved. PowerShow.com is a trademark of CrystalGraphics, Inc.
cber — Search results on PowerShow.com